Abstract
Children with psoriasis present unique challenges for providers. These include under-recognition by primary care providers, unusual presentations, and accessibility to effective, safe medication since few intervention studies are performed in children and no systemic medications are currently approved by the U.S. Food and Drug Administration (FDA).
| Original language | English (US) |
|---|---|
| Title of host publication | Psoriasis, Second Edition |
| Publisher | CRC Press |
| Pages | 149-157 |
| Number of pages | 9 |
| ISBN (Electronic) | 9781498700535 |
| ISBN (Print) | 9781498700528 |
| DOIs | |
| State | Published - Jan 1 2017 |
ASJC Scopus subject areas
- Medicine(all)